How cells die determines whether immune system mounts response

User rating: 4.5 / 5 after 4 vote(s)

Every moment we live, cells in our bodies are dying. One type of cell death activates an immune response while another type doesn't. Now researchers at Washington University School of Medicine in St. Louis and St. Jude's Children's Research Hospital in Memphis have figured out how some dying cells signal the immune system. They say the finding eventually could have important implications in the treatment of autoimmune diseases and cancer.


Full story »

All News summaries from Medicine & Health news
All News summaries for July 17, 2008

Researchers discover baldness gene: 1 in 7 men at risk

Oct 12, 2008 | User rating: not rated yet
Researchers at McGill University, King's College London and GlaxoSmithKline Inc. have identified two genetic variants in caucasians that together produce an astounding sevenfold increase the risk of male pattern baldness. ...

Body's anti-HIV drug explained

Oct 12, 2008 | User rating: not rated yet
Humans have a built-in weapon against HIV, but until recently no one knew how to unlock its potential.

Pandemic flu models help determine food distribution and school closing strategies

Oct 12, 2008 | User rating: not rated yet
The 1918 flu pandemic killed more than 40 million people worldwide and affected persons of all age groups. While it is difficult to predict when the next influenza pandemic will occur or how severe it will be, researchers ...

Study reveals that signs of heart disease are attributed to stress more frequently in women than men

Oct 12, 2008 | User rating: not rated yet
Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), found that coronary heart disease (CHD) symptoms presented ...

Drug may reduce coronary artery plaque

Oct 12, 2008 | User rating: not rated yet
Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggests that olmesartan, a drug commonly used to treat ...